ak 3012
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2012 (NCT01757613)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ak 3012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01757613 | Phase 2 | Dec 1, 2012 | CenTrial GmbH, Dolorgiet GmbH & Co. KG, d.s.h. statistical services GmbH |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CenTrial GmbH | For profit | 1 | 0 | 1 | 2012 |
| Dolorgiet GmbH & Co. KG | For profit | 1 | 1 | 1 | 2012 |
| d.s.h. statistical services GmbH | For profit | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1